###begin article-title 0
RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium
###end article-title 0
###begin p 1
###xml 49 67 49 67 <email xmlns:xlink="http://www.w3.org/1999/xlink">rr260@columbia.edu</email>
Corresponding author: Dr. Ravichandran Ramasamy, rr260@columbia.edu
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
###xml 383 386 <span type="species:ncbi:10116">rat</span>
OBJECTIVE-Subjects with diabetes experience an increased risk of myocardial infarction and cardiac failure compared with nondiabetic age-matched individuals. The receptor for advanced glycation end products (RAGE) is upregulated in diabetic tissues. In this study, we tested the hypothesis that RAGE affected ischemia/reperfusion (I/R) injury in the diabetic myocardium. In diabetic rat hearts, expression of RAGE and its ligands was enhanced and localized particularly to both endothelial cells and mononuclear phagocytes.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
RESEARCH DESIGN AND METHODS-To specifically dissect the impact of RAGE, homozygous RAGE-null mice and transgenic (Tg) mice expressing cytoplasmic domain-deleted RAGE (DN RAGE), in which RAGE-dependent signal transduction was deficient in endothelial cells or mononuclear phagocytes, were rendered diabetic with streptozotocin. Isolated perfused hearts were subjected to I/R.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
RESULTS-Diabetic RAGE-null mice were significantly protected from the adverse impact of I/R injury in the heart, as indicated by decreased release of LDH and lower glycoxidation products carboxymethyl-lysine (CML) and pentosidine, improved functional recovery, and increased ATP. In diabetic Tg mice expressing DN RAGE in endothelial cells or mononuclear phagocytes, markers of ischemic injury and CML were significantly reduced, and levels of ATP were increased in heart tissue compared with littermate diabetic controls. Furthermore, key markers of apoptosis, caspase-3 activity and cytochrome c release, were reduced in the hearts of diabetic RAGE-modified mice compared with wild-type diabetic littermates in I/R.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-These findings demonstrate novel and key roles for RAGE in I/R injury in the diabetic heart.
###end p 6
###begin p 7
Published ahead of print at  on 16 April 2008.
###end p 7
###begin p 8
L.G.B. is currently affiliated with Istituto Clinico Humanitas, Istituto di Ricovero e Cura a Carattere Scientifico, Rozzano, Italy.
###end p 8
###begin p 9
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 9
###begin p 10
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 602 603 602 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 604 605 604 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
Cardiac complications remain a leading cause of morbidity and mortality in subjects with diabetes (1-3). Although many factors contribute to depressed cardiac function in diabetes, innate disturbances within the diabetic heart contribute importantly to progressive dysfunction, which often leads to irreversible failure and death (3). Alterations in substrate metabolism and increased levels of oxygen free radicals have been observed in diabetic tissues. Inflammatory cytokines may exert direct negative inotropic effects on cardiac myocytes and contribute to aberrant remodeling in the failed heart (4-8). The pathophysiology of diabetes-associated cardiac complications is complex and involves a host of factors linked to metabolic and immune/inflammatory cell activation.
###end p 10
###begin p 11
###xml 301 302 301 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
The accumulation of late-stage glycoxidation adducts of proteins, termed advanced glycation end products (AGEs), occurs in diabetic tissues. AGEs modify long-lived molecules in the blood vessel wall and structural tissues of the heart considerably earlier than symptomatic cardiac dysfunction occurs (9). A major way in which AGEs exert their cellular effects is by ligation of the multiligand receptor for AGE (RAGE) (10-13).
###end p 11
###begin p 12
We tested the role of RAGE in rodent models of type 1 diabetes, and we show that pharmacological blockade of ligand-RAGE interaction or genetic modulation of RAGE suppresses ischemia/reperfusion (I/R) injury in the isolated perfused heart, at least in part secondary to critical contributions evoked from RAGE-expressing endothelial cells and mononuclear phagocytes in the diabetic heart.
###end p 12
###begin title 13
RESEARCH DESIGN AND METHODS
###end title 13
###begin p 14
###xml 147 195 147 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Guide for the Care and Use of Laboratory Animals</italic>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 1131 1133 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 274 278 <span type="species:ncbi:10116">rats</span>
###xml 362 366 <span type="species:ncbi:10116">Rats</span>
###xml 501 505 <span type="species:ncbi:10116">rats</span>
###xml 530 534 <span type="species:ncbi:10116">rats</span>
###xml 554 559 <span type="species:ncbi:9606">human</span>
###xml 708 712 <span type="species:ncbi:10116">Rats</span>
###xml 764 770 <span type="species:ncbi:10090">Murine</span>
All animal studies were performed with the approval of the Institutional Animal Care and Use Committee of Columbia University and conform with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health. Male diabetic Bio Bred (BB/W) rats, a model of type 1 diabetes (Biomedical Models, Worcester, MA) (14,15), were used. Rats became diabetic between 69 and 80 days of age and were entered into study at diagnosis of hyperglycemia. Age-matched nondiabetic BB/W rats were controls. Diabetic rats were maintained on human insulin (3-5 units/dose) (Humulin; Eli Lilly, Indianapolis, IN) twice daily. Insulin was discontinued 12 h before isolated heart perfusion studies. Rats were killed after 2 weeks of established diabetes. Murine soluble RAGE (sRAGE; 500 mug/day) or equal volumes of its diluent, PBS, were administered by intraperitoneal route beginning immediately at the diagnosis of hyperglycemia (serum glucose >/=250 mg/dl) and continued for 14 days. sRAGE was prepared in a baculovirus expression system, and the material was purified and devoid of contaminating lipopolysaccharide (16).
###end p 14
###begin p 15
###xml 333 335 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">Mice</span>
Male BALB/c or C57BL/6 mice (The Jackson Laboratories, Bar Harbor, ME) were rendered diabetic by 55 mg/kg i.p. streptozotocin (STZ) per day in fresh citrate buffer (0.05 mol/l; pH 4.5) for 5 consecutive days. Mice displaying serum glucose >/=250 mg/dl were considered diabetic. Control (nondiabetic) animals received citrate buffer (16).
###end p 15
###begin title 16
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 30 45 <span type="species:ncbi:10090">transgenic mice</span>
Homozygous RAGE-null mice and transgenic mice.
###end title 16
###begin p 17
###xml 37 39 37 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 40 42 40 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 177 192 <span type="species:ncbi:10090">transgenic mice</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">Mice</span>
Homozygous RAGE-null mice (RAGE-KO) (17-19) were backcrossed 10 generations into C57BL/6 before study. Male RAGE-KO and littermate mice were used. In other studies, two sets of transgenic mice were prepared to express signal transduction-deficient RAGE, or dominant-negative (DN) RAGE (11,12,18) in endothelial cells (driven by the preproendothelin-1 [PPET] promoter; 20) or cells of mononuclear phagocyte lineage (driven by the macrophage scavenger receptor type A [MSR] promoter; 21,22). Transgenic (Tg) DN MSR RAGE and Tg DN PPET RAGE mice were prepared and characterized as previously described (20,22). Mice were backcrossed >10 generations into C57BL/6 before the study. Littermates not expressing the transgene were used as controls.
###end p 17
###begin title 18
Western blotting.
###end title 18
###begin p 19
###xml 104 106 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
Left ventricles were retrieved and subjected to SDS-PAGE/Western blotting using 1 mug/ml anti-RAGE IgG (16); 0.25 mug/ml anti-inducible nitric oxide (NO) synthase (iNOS) IgG (Santa Cruz Biotechnology); anti-cytochrome c IgG (Santa Cruz Biotechnology); or anti-glyceraldehydes-3-phosphate dehydrogenase (GAPDH) IgG (Cayman). After probing with the primary antibodies, membranes were stripped of bound immunoglobulins and reprobed with anti-beta-actin IgG (Sigma-Aldrich, St. Louis, MO). All antibodies were used according to the manufacturer's instructions. Analysis of band density was performed using Image Quant/Molecular Dynamics software (Foster City, CA). Results are reported as relative units based on the ratio of test antibody densitometry units/beta-actin densitometry units.
###end p 19
###begin title 20
Immunohistochemistry.
###end title 20
###begin p 21
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
Hearts were retrieved, and sections were prepared for immunohistochemistry. The following antibodies were used: anti-RAGE IgG (16), anti-AGE IgG (16), anti-S100/calgranulin IgG (12), and anti-nitrotyrosine IgG (Upstate, Lake Placid, NY). To localize cell-specific expression of RAGE, additional antibodies were used: anti-Mac 3 IgG (Pharmingen, San Diego, CA) and anti-CD31 IgG (Pharmingen). Immunostaining with nonimmune IgGs of the relevant species were negative.
###end p 21
###begin title 22
Levels of total nitrite and nitrate and cGMP.
###end title 22
###begin p 23
Hearts were retrieved and rapidly snap-frozen in liquid nitrogen after I/R. Lysates were prepared and levels of total nitrite and nitrate and cGMP were measured using a kit from Oxis Research Products (Portland, OR).
###end p 23
###begin title 24
Isolated perfused heart and measurement of cardiac function.
###end title 24
###begin p 25
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 630 631 624 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 648 649 642 643 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 666 667 660 661 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 800 801 794 795 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 807 808 801 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 839 840 833 834 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 127 131 <span type="species:ncbi:10090">Mice</span>
###xml 136 140 <span type="species:ncbi:10116">rats</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 458 462 <span type="species:ncbi:10116">rats</span>
###xml 500 503 <span type="species:ncbi:10116">Rat</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
Experiments were performed using an isovolumic isolated heart preparation and modified, as indicated, for mice hearts (23,24). Mice and rats were anesthetized using a mixture of ketamine and xylazine (80 and 10 mg/kg, respectively). After deep anesthesia was achieved, hearts were rapidly excised, placed in iced saline, and retrogradely perfused at 37degreesC in a nonrecirculating mode through the aorta. In mice, the perfusion rate was 2.5 ml/min, and in rats, the perfusion rate was 12.5 ml/min. Rat and mice hearts were perfused with modified Krebs-Henseleit buffer containing 118 mmol/l NaCl, 4.7 mmol/l KCl, 2.5 mmol/l CaCl2, 1.2 mmol/l MgCl2, 25 mmol/l NaHCO3, 5 mmol/l glucose, 0.4 mmol/l palmitate, 0.4 mmol/l BSA, and 70 mU/l insulin. The perfusate was equilibrated with a mixture of 95% O2-5% CO2, which maintained perfusate PO2 >600 mmHg. Left ventricular developed pressure (LVDP) and left ventricular end diastolic pressure were measured using a latex balloon in the left ventricle. LVDP, heart rate, and coronary perfusion pressure were monitored continuously on a four-channel Powerlab (AD Instruments, Grand Junction, CO).
###end p 25
###begin p 26
###xml 108 112 <span type="species:ncbi:10090">Mice</span>
###xml 210 213 <span type="species:ncbi:10116">Rat</span>
The ischemia/perfusion protocol was as follows: Hemodynamic function was monitored throughout the protocol. Mice hearts were paced at 420 beats/min with the use of pacing electrodes placed on the right atrium. Rat hearts were paced at 300 beats/min. Hearts were subjected to 30 min of global (zero-flow) ischemia and 60 min of reperfusion. Perfusate temperature was maintained at 37degreesC at all times during the protocol (i.e., during baseline, ischemia, and reperfusion). After an equilibration period of 30 min, both groups of hearts were perfused with modified Krebs-Henseleit buffer throughout ischemia and reperfusion.
###end p 26
###begin p 27
###xml 517 518 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 618 623 <span type="species:ncbi:9606">human</span>
LDH release, a marker of I/R injury, was measured in the effluents for the entire 60 min of reperfusion in each heart. The levels of LDH were assayed using commercially available kits from Sigma-Aldrich. LDH release is expressed as international unit per gram dry weight of tissue. Caspase-3 activity was assayed in hearts using reagents provided in the caspase-3 activity kit from R&D Systems. Briefly, caspase-3 activity is based on cleavage of the synthetic caspase substrate linked to the color reporter molecule p-nitroaniline. The amount of hydrolyzed substrate was measured as absorbance at 405 nm. Recombinant human caspase-3 was used as a positive control and to generate a standard curve. The results are expressed as caspase activity relative to that of wild-type control animals.
###end p 27
###begin title 28
Measurement of ATP.
###end title 28
###begin p 29
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
ATP was measured in the neutralized perchloric acid extracts of hearts according to previously published procedures (23,24).
###end p 29
###begin title 30
Determination of AGEs in heart tissue.
###end title 30
###begin p 31
###xml 1249 1251 1229 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 1349 1351 1329 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
Heart tissue (25-100 mg wet wt) was extracted with 10 ml 2:1 chloroform-methanol for 24 h, washed with 10 ml methanol, and rehydrated in water. Samples were homogenized for 60 s with a Brinkmann Polytron in 2 ml Chelex-treated PBS (pH 7.4) containing 1 mmol/l diethylenetriaminepentaacetic acid (DTPA) and protease inhibitor cocktail (Roche) using one tablet per 10 ml buffer. Homogenates were centrifuged at 1,600 rpm for 20 min using a Sorvall RT 6000D centrifuge. Pellets were washed three times with water while supernatants were exhaustively dialyzed versus water. All samples were freeze-dried and stored at -80degreesC until further processing. Three milligrams of lyophilized tissue was weighed and placed into Eppendorf tubes on ice. Samples were solubilized with 100 mul PBS and 900 mul 1% HCl/Acetone kept at -20degreesC to remove heme, vortexed, and centrifuged at 15,000 rpm for 15 min at 4degreesC. This procedure was repeated twice. Pellets were then washed with ice-cold 1 mmol/l DTPA, freeze-dried, and acid hydrolyzed with 6 N HCl for 19 h. AGE analysis (carboxymethyl-lysine [CML], carboxyethyl-lysine [CEL], fructose-lysine [furosine], and 2-aminoadipic acid) was by gas chromatography-mass spectrometry as described previously (25). Pentosidine was determined by high-performance liquid chromatography according to Sell et al. (26)
###end p 31
###begin title 32
Statistical analysis.
###end title 32
###begin p 33
###xml 308 309 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Significant differences between experimental groups were detected using ANOVA for unpaired variables. Post hoc comparisons were performed using Tukey's or Dunnett's procedures as indicated. SAS package software was used in the statistical analyses, and statistical significance was ascribed to the data when P < 0.05.
###end p 33
###begin title 34
RESULTS
###end title 34
###begin title 35
###xml 33 36 <span type="species:ncbi:10116">rat</span>
Ligand/RAGE axis in the diabetic rat heart.
###end title 35
###begin p 36
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 468 469 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 462 469 462 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 585 586 585 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 579 586 579 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 734 735 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 728 735 728 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 811 812 811 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 805 812 805 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 37 40 <span type="species:ncbi:10116">rat</span>
###xml 263 266 <span type="species:ncbi:10116">rat</span>
###xml 527 531 <span type="species:ncbi:10116">rats</span>
###xml 722 726 <span type="species:ncbi:10116">rats</span>
###xml 794 797 <span type="species:ncbi:10116">rat</span>
We used the Biobred/Worcester (BB/W) rat, a model of autoimmune type 1 diabetes, to dissect the potential role of RAGE in the pathogenesis of cardiac dysfunction in diabetes (14,15) and explored the expression/distribution of RAGE and its ligands in the diabetic rat heart at baseline, in the absence of I/R. First, we examined epitopes for CML AGEs (27,28). CML AGEs are specific AGE ligands of RAGE (11). In nondiabetic hearts, CML epitopes were not detected (Fig. 1A). In contrast, heart tissue retrieved from hyperglycemic rats displayed immunoreactive epitopes for CML AGE (Fig. 1B). In addition to AGEs, although expression of RAGE ligand S100/calgranulin (12) was not demonstrated in the hearts of nondiabetic BB/W rats (Fig. 1C), S100/calgranulin epitopes were evident in diabetic BB/W rat heart (Fig. 1D), in both vascular cells and cardiomyocytes.
###end p 36
###begin p 37
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 112 125 112 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>F</italic> and <italic>E</italic></xref>
###xml 163 164 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 179 180 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 173 180 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>M</italic></xref>
###xml 471 472 471 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 477 478 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 465 478 465 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>G</italic> and <italic>H</italic></xref>
###xml 459 463 <span type="species:ncbi:10116">rats</span>
Diabetic BB/W hearts displayed increased RAGE antigen compared with nondiabetic hearts by immunohistochemistry (Fig. 1F and E, respectively) and Western blotting (P < 0.05; Fig. 1M). We examined the hearts to detect nitrotyrosine epitopes, markers of oxidative injury. Compared with nondiabetic hearts in which virtually no nitrotyrosine epitopes were evident, immunohistochemistry demonstrated extensive nitrotyrosine epitopes in the hearts of diabetic BB/W rats (Fig. 1G and H, respectively).
###end p 37
###begin p 38
###xml 249 250 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 255 256 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J</italic>
###xml 243 256 243 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>I</italic> and <italic>J</italic></xref>
###xml 425 426 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 431 432 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 419 432 419 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>K</italic> and <italic>L</italic></xref>
To specifically localize the cells expressing RAGE in the diabetic heart, additional studies were performed. Immunohistochemistry using anti-RAGE IgG and anti-CD31 IgG showed that RAGE was expressed in endothelial cells in the diabetic heart (Fig. 1I and J, respectively). Immunohistochemistry using anti-RAGE IgG and anti-Mac-3 IgG demonstrated that RAGE was expressed in mononuclear phagocytes in the diabetic heart (Fig. 1K and L, respectively). Together, these studies indicated that RAGE expression was increased in the type 1 diabetic heart, particularly in endothelial cells and mononuclear phagocytes.
###end p 38
###begin p 39
###xml 426 427 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 442 443 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 436 443 436 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>M</italic></xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 200 204 <span type="species:ncbi:10116">rats</span>
###xml 286 290 <span type="species:ncbi:10116">rats</span>
###xml 420 424 <span type="species:ncbi:10116">rats</span>
###xml 692 696 <span type="species:ncbi:10116">rats</span>
To test the impact of diabetes on expression of RAGE and the effects of RAGE blockade, we first administered sRAGE, the extracellular ligand-binding domain of RAGE. sRAGE was administered to diabetic rats commencing at the diagnosis of hyperglycemia once daily for 14 days. In diabetic rats treated with sRAGE, significantly lower levels of RAGE antigen in the heart were observed compared with vehicle-treated diabetic rats (P < 0.05; Fig. 1M). This observation is consistent with the concept that ligand-RAGE interaction sustains enhanced expression of RAGE; once interrupted, cellular expression of RAGE was significantly lower than that observed in the hearts of vehicle-treated diabetic rats (29).
###end p 39
###begin title 40
###xml 45 48 <span type="species:ncbi:10116">rat</span>
Diabetes increases expression of iNOS in the rat heart: impact of RAGE.
###end title 40
###begin p 41
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 398 399 398 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 392 399 392 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 233 237 <span type="species:ncbi:10116">rats</span>
To explore the potential impact of the ligand-RAGE axis in modulating perturbation and oxidant stress in the heart, we assessed levels of iNOS in the heart in the basal state. Compared with nondiabetic controls, hearts from diabetic rats displayed increased iNOS antigen by Western blotting; in the presence of treatment with sRAGE, levels of iNOS antigen were significantly lower (P < 0.05; Fig. 2A).
###end p 41
###begin p 42
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 294 295 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 300 301 300 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 288 301 288 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic> and <italic>C</italic></xref>
In parallel, levels of total nitrite and nitrate and cGMP were increased in diabetes (P < 0.05); in the presence of sRAGE, levels of total nitrite and nitrate and cGMP in diabetic hearts were significantly lower (P < 0.05) and similar to those observed in nondiabetic age-matched hearts (Fig. 2B and C, respectively).
###end p 42
###begin title 43
###xml 83 86 <span type="species:ncbi:10116">rat</span>
Pharmacological blockade of ligand-RAGE axis attenuates I/R injury in the diabetic rat heart.
###end title 43
###begin p 44
###xml 380 381 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 396 397 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 390 397 390 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 490 491 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 506 507 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 500 507 500 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 621 622 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 637 638 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 643 644 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 631 644 631 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic> and <italic>B</italic></xref>
###xml 98 101 <span type="species:ncbi:10116">rat</span>
###xml 247 251 <span type="species:ncbi:10116">rats</span>
###xml 338 342 <span type="species:ncbi:10116">rats</span>
We assessed the potential impact of RAGE on cardiac dysfunction consequent to I/R in the diabetic rat heart. Two indexes of cardiac recovery were assessed: LVDP and release of LDH on reperfusion, the latter an index of myocardial injury. Diabetic rats displayed a marked decrease in LVDP recovery on reperfusion compared with nondiabetic rats subjected to the same degree of I/R (P < 0.05; Fig. 3A). LDH release was significantly higher in diabetic hearts compared with nondiabetic hearts (P < 0.05; Fig. 3B). Treatment for 14 days with sRAGE resulted in improvement in LVDP recovery and significantly lower LDH release (P < 0.05; Fig. 3A and B).
###end p 44
###begin title 45
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Role of RAGE in diabetes-associated cardiac ischemic injury: studies in mice.
###end title 45
###begin p 46
###xml 451 458 451 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 632 639 632 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 839 846 839 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 1187 1188 1187 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1203 1204 1203 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1197 1204 1197 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 1293 1294 1293 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 27 33 <span type="species:ncbi:10090">murine</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 437 442 <span type="species:ncbi:10090">mouse</span>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 1219 1223 <span type="species:ncbi:10090">mice</span>
We extended our studies to murine models, wherein genetic modification of RAGE would complement pharmacological blockade of ligand-RAGE interaction (sRAGE). We rendered wild-type BALB/c mice diabetic with STZ and examined the impact of hyperglycemia on expression of RAGE and its ligands in the heart. After 14 days of diabetes, we examined levels of specific AGE species, CML, CEL, furosine (glycated lysine), and pentosidine in BALB/c mouse hearts (Table 1). As expected, we found that levels of CML, furosine, and pentosidine were significantly higher in the diabetic BALB/c mice hearts compared with their nondiabetic controls (Table 1). In diabetic mice, treatment with sRAGE prevented the increases in CML and pentosidine levels, but there was no effect on furosine levels, suggesting an effect independent of tissue glucose levels (Table 1). Levels of argpyramidine, CEL, and 2-aminoadipic acid, a marker of metal catalyzed oxidation, were similar in all of the groups studied (data not shown). Consistent with increased AGE ligand levels in the diabetic heart, a significant increase in RAGE antigen by Western blotting was observed in diabetic compared with nondiabetic hearts (P < 0.05; Fig. 4A). In diabetic mice treated with sRAGE, levels of RAGE antigen were significantly lower (P < 0.05) and not different from levels observed in euglycemic controls.
###end p 46
###begin p 47
###xml 268 269 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 284 285 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 278 285 278 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 355 356 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 371 372 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 365 372 365 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 511 512 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 527 528 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 533 534 533 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 521 534 521 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>C</italic> and <italic>D</italic></xref>
###xml 728 729 728 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 744 745 744 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 738 745 738 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>E</italic></xref>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 234 239 <span type="species:ncbi:10090">mouse</span>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
To test the impact of diabetes on oxidant stress in the diabetic heart, we examined levels of iNOS antigen in the basal state. Compared with nondiabetic mice, significant increases in iNOS antigen were demonstrated in diabetic BALB/c mouse hearts by Western blotting (P < 0.05; Fig. 4B). In the presence of sRAGE, levels of iNOS were significantly lower (P < 0.05; Fig. 4B). In parallel, levels of total nitrite and nitrate and cGMP were increased in the diabetic versus nondiabetic heart and reduced by sRAGE (P < 0.05; Fig. 4C and D, respectively). When hearts were subjected to I/R, significantly less release of LDH was demonstrated in hearts retrieved from sRAGE-treated diabetic mice versus vehicle-treated diabetic mice (P < 0.05; Fig. 4E).
###end p 47
###begin title 48
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Diabetic homozygous RAGE-KO mice.
###end title 48
###begin p 49
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
To specifically address the contribution of RAGE, we used homozygous RAGE-KO mice. RAGE-KO mice or wild-type RAGE-expressing littermate animals were rendered diabetic with STZ. We extended the period of diabetes to 12 weeks to test the impact of RAGE in a chronically diabetic environment.
###end p 49
###begin p 50
###xml 201 202 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 217 218 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 211 218 211 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 384 385 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 400 401 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 394 401 394 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 514 515 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 530 531 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 524 531 524 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
We assessed the impact of injury triggered by I/R on functional recovery of the diabetic heart. LVDP recovery was significantly higher in the diabetic RAGE-KO heart versus RAGE-expressing littermates (P < 0.05; Fig. 5A). In parallel, levels of LDH measured in the effluent in the I/R-subjected diabetic animals were significantly lower in the diabetic RAGE-KO versus littermate mice (P < 0.05; Fig. 5B). Levels of ATP in the heart were significantly higher in the diabetic RAGE-KO hearts versus diabetic controls (P < 0.05; Fig. 5C).
###end p 50
###begin p 51
###xml 169 170 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 337 338 328 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Levels of total nitrite and nitrate after I/R were significantly lower in diabetic RAGE-KO versus wild-type diabetic hearts (2.9 +/- 0.9 vs. 6.8 +/- 1.1 mumol/g tissue; P < 0.05). Furthermore, levels of cGMP in the diabetic heart were lower after I/R in RAGE-KO versus wild-type diabetic hearts (206 +/- 66 vs. 616 +/- 86 pmol/g tissue; P < 0.05).
###end p 51
###begin p 52
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
Based on these findings in diabetic mice with global deletion of RAGE, we addressed the specific roles of RAGE signaling in endothelial cells or mononuclear phagocytes on I/R stress in the heart. As endothelial cells and mononuclear phagocytes were principal RAGE-expressing cells in the diabetic heart, we used two sets of Tg mice in which RAGE signal transduction was deficient based on introduction of a transgene encoding cytoplasmic DN RAGE in these cell types.
###end p 52
###begin title 53
###xml 3 7 <span type="species:ncbi:10090">mice</span>
Tg mice expressing DN RAGE in endothelial cells.
###end title 53
###begin p 54
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 336 337 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 330 337 330 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 256 261 <span type="species:ncbi:10090">mouse</span>
To dissect the role of RAGE signaling in endothelial cell in the diabetic heart, we generated Tg mice in which DN RAGE expression was directed to endothelial cells by the PPET (20). Immunostaining with anti-RAGE IgG revealed that RAGE expression in the Tg mouse heart was localized to endothelial cells and not to cardiomyocytes (Fig. 6A).
###end p 54
###begin p 55
###xml 301 302 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 323 324 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 311 324 311 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>B</italic> and <italic>C</italic></xref>
###xml 481 482 481 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 497 498 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 503 504 503 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 491 504 491 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>D</italic> and <italic>E</italic></xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
Mice were rendered diabetic with STZ. Hearts were excised after 12 weeks of hyperglycemia and subjected to the isolated perfused heart protocol. On induction of ischemia or I/R, levels of iNOS antigen in the heart were significantly higher in wild-type mice versus Tg DN PPET RAGE mice with diabetes (P < 0.05; Fig. 6B and C). In parallel, levels of total nitrite and nitrate were significantly lower in the diabetic Tg DN PPET RAGE mice hearts versus littermate hearts after I/R (P < 0.05; Fig. 6D and E, respectively).
###end p 55
###begin p 56
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 260 261 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 254 261 254 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>F</italic></xref>
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 376 383 376 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>G</italic></xref>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
To assess the impact of DN RAGE in endothelial cells in I/R injury in the diabetic heart, levels of LDH were measured in the effluent. LDH release was significantly less in the diabetic Tg DN PPET RAGE hearts versus wild-type hearts after I/R (P < 0.05; Fig. 6F). Levels of ATP in the heart were significantly higher in the diabetic Tg mice versus wild-type hearts after I/R (Fig. 6G). In contrast, LVDP recovery was not significantly different between the diabetic Tg DN PPET RAGE versus diabetic wild-type littermate hearts after I/R (LVDP recovery on reperfusion was 39 +/- 14% in diabetic Tg DN PPET RAGE vs. 46 +/- 11% in diabetic nontransgenic littermate hearts). These findings suggest that the impact of RAGE signaling in endothelial cells influences injury but not functional recovery.
###end p 56
###begin title 57
###xml 3 7 <span type="species:ncbi:10090">mice</span>
Tg mice expressing DN RAGE in cells of mononuclear phagocyte lineage.
###end title 57
###begin p 58
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
To dissect the potential role of mononuclear phagocyte RAGE signaling in modulating the response to diabetes and I/R in the heart, we previously prepared Tg mice expressing DN RAGE selectively in cells of mononuclear phagocyte lineage using the scavenger receptor type A promoter (referred to as MSR DN RAGE) (22). DN RAGE was selectively expressed in mononuclear phagocyte, and there was no evidence that transgene expression was extended outside of monocytes/macrophages (22).
###end p 58
###begin p 59
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 153 160 153 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>A</italic></xref>
###xml 211 212 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 205 212 205 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>B</italic></xref>
###xml 360 361 360 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 376 377 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 370 383 370 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>C</italic> and <italic>D</italic></xref>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
Consequent to ischemia, significantly higher iNOS antigen was expressed in the diabetic wild-type heart versus Tg DN MSR Tg DN MSR RAGE heart (P < 0.05; Fig. 7A). Similar findings were observed after I/R (Fig. 7B). In parallel, diabetic Tg DN MSR Tg DN MSR RAGE mice hearts displayed significantly decreased levels of total nitrate/nitrite and cGMP after I/R (P < 0.05; Fig. 7C and D, respectively).
###end p 59
###begin p 60
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 256 263 256 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>E</italic></xref>
###xml 404 405 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 420 421 420 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 414 421 414 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>F</italic></xref>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
We examined the impact of the DN RAGE transgene in mononuclear phagocyte on I/R injury in the diabetic heart. Significantly less LDH release was observed after I/R in the diabetic Tg DN MSR Tg DN MSR RAGE heart versus diabetic littermate hearts (P < 0.05; Fig. 7E). Furthermore, levels of ATP in the hearts of diabetic Tg mice were significantly higher than those observed in diabetic littermate hearts (P < 0.05; Fig. 7F). LVDP recovery on reperfusion was similar in both the diabetic Tg and littermate hearts (LVDP recovery on reperfusion was 47 +/- 11% in diabetic Tg DN MSR RAGE vs. 41 +/- 9% in diabetic nontransgenic littermate hearts).
###end p 60
###begin title 61
###xml 17 21 <span type="species:ncbi:10090">mice</span>
AGEs in diabetic mice hearts subjected to I/R.
###end title 61
###begin p 62
###xml 205 212 205 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 521 528 521 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
We examined the levels of specific AGEs, CML, pentosidine, and furosine (glycated lysine) in diabetic wild-type, RAGE-KO, Tg DN PPET RAGE, and Tg DN MSR RAGE heart under baseline conditions and after I/R (Table 2). In the baseline condition, CML, furosine, and pentosidine levels were significantly lower in diabetic RAGE-KO versus diabetic wild-type hearts. In diabetic Tg DN PPET RAGE, and Tg DN MSR RAGE mice hearts, concentrations of CML, furosine, and pentosidine were similar to those in diabetic wild-type hearts (Table 2). CEL, argpyrimidine, and 2-aminoadipic acid were similar in all the groups of hearts studied here (data not shown).
###end p 62
###begin p 63
###xml 167 174 167 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 991 995 <span type="species:ncbi:10090">mice</span>
Interestingly, after I/R, CML levels were significantly greater in diabetic WT hearts in comparison with diabetic RAGE-KO, Tg DN PPET RAGE, and Tg DN MSR RAGE hearts (Table 2). Furosine was significantly reduced in diabetic RAGE-KO and Tg DN PPET RAGE hearts versus diabetic wild-type or Tg DN MSR RAGE hearts after I/R. Pentosidine was significantly attenuated in diabetic RAGE-KO and Tg DN MSR RAGE versus diabetic wild-type or Tg DN PPET RAGE hearts after I/R. I/R increased CML by 20% in wild-type diabetic hearts but not in RAGE-KO D and Tg DN MSR D. These data indicate that CML, pentosidine, and furosine are significantly reduced in diabetic RAGE-KO hearts under all perfusion conditions, whereas in Tg DN PPET RAGE and Tg DN MSR RAGE hearts, only CML levels are attenuated under all perfusion conditions. Thus, these data indicate that suppressive effect of DN RAGE on pentosidine is cell specific, i.e., expression of DN RAGE reduced pentosidine in Tg DN MSR but not in Tg DN PPET mice hearts. Furthermore, data indicate that most of CML effects appear to be associated with the endothelial cells, whereas pentosidine effects are pronounced in the mononuclear phagocytes.
###end p 63
###begin title 64
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Effect of RAGE deletion on apoptosis in diabetic mice hearts after I/R.
###end title 64
###begin p 65
###xml 243 244 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 237 244 237 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f8" ref-type="fig">Fig. 8<italic>A</italic></xref>
###xml 385 386 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 435 436 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 429 436 429 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f8" ref-type="fig">Fig. 8<italic>B</italic></xref>
###xml 568 569 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
To determine whether the RAGE-ligand interaction mediates cell death in the diabetic heart consequent to I/R, we performed analyses to probe apoptotic signals, such as cytochrome c release and caspase-3 activation. Caspase-3 activation (Fig. 8A) was significantly reduced in diabetic RAGE RAGE-KO, Tg DN PPET RAGE, and Tg DN MSR RAGE hearts versus diabetic wild-type hearts after I/R (P < 0.05). Similarly, cytochrome c release (Fig. 8B) was also reduced in diabetic RAGE RAGE-KO, Tg DN PPET RAGE, and Tg DN MSR RAGE hearts versus diabetic wild-type hearts after I/R (P < 0.05).
###end p 65
###begin p 66
###xml 234 241 234 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
###xml 220 224 <span type="species:ncbi:10116">rats</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
Of note, pharmacological blockade of RAGE, by administration of sRAGE, or genetic deletion or modulation of RAGE signaling in endothelial cells or mononuclear phagocyte had no impact on the levels of glucose in diabetic rats or mice (Table 3).
###end p 66
###begin title 67
DISCUSSION
###end title 67
###begin title 68
RAGE and NOS.
###end title 68
###begin p 69
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 895 897 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
In diabetes, cells within the vascular milieu produce NO and superoxide, at least in part, via the direct action of glucose itself and by its downstream effector species, such as AGEs (30). The generation of a potent longer-lived oxidant peroxynitrite, due to interaction of NO and superoxide, has deleterious consequences, such as inhibition of mitochondrial electron transport, oxidation of sulfhydryl groups in proteins, initiation of lipid peroxidation, nitration of amino acids (31), and uncoupling of endothelial NO synthase by peroxynitrite leading to amplification of oxidant stress (32). Peroxynitrite induces formation of CML-modified adducts by cleavage of Amadori products and the generation of glucosone and glyoxal from glucose, thus providing a "refueling mechanism" by which diabetes-mediated generation of CML leads to oxidant stress and, in part, regeneration of CML epitopes (33).
###end p 69
###begin p 70
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
It is likely that inhibition of the synthesis of NO by iNOS plays an important role. Our results are consistent with previous studies of acute ischemia and reperfusion in which administration of semi-selective inhibitors of iNOS or iNOS-null mice enhanced cardiac performance and/or reduced myocardial infarct size (34-37). Previous studies showed that iNOS played critical roles in diabetes and I/R in the heart, because iNOS-null mice displayed protection from the adverse effect of this injury, especially in diabetes (38). Our findings definitively link RAGE and RAGE signaling in endothelial cells and mononuclear phagocyte to generation of NO and pathogenic oxidant stress species in the diabetic heart. The impact of DN RAGE in both endothelial cells and mononuclear phagocyte is likely explained, in part, by the fundamental interplay and cross-talk between the molecular and biochemical consequences of endothelial cells and mononuclear phagocyte activation.
###end p 70
###begin title 71
RAGE and myocardial energy metabolism.
###end title 71
###begin p 72
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r40">40</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r41">41</xref>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
Our studies indicate that RAGE influenced myocardial energy metabolism. At the end of global ischemia, levels of cardiac ATP were reduced significantly in all hearts; however, higher levels of ATP were observed in diabetic RAGE signaling mutant Tg mice or RAGE-KO mice compared with diabetic littermates. In global ischemia, ATP production results primarily from anaerobic glycolysis. Nitrosylation of GAPDH is a potential mechanism by which NO is likely to mediate inhibition of anaerobic glycolysis during global ischemia (39,40). Recent findings from our laboratory demonstrated reduced myocardial GAPDH activity and levels of glyceraldehyde-3-phosphate at the end of the ischemic period and normalization of these changes by inhibition of iNOS (41). Higher iNOS expression and NO production have been shown, in part, to impair glycolysis and to reduce ATP levels in ischemic hearts. Our data demonstrating reduced iNOS expression, total nitrite and nitrate levels, and improved ATP levels in RAGE-inhibited ischemic hearts are consistent, in part, with RAGE blockade improving anaerobic glycolysis.
###end p 72
###begin title 73
RAGE and cardiac ischemic injury.
###end title 73
###begin p 74
###xml 251 252 251 252 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 259 260 259 260 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 261 262 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 262 263 262 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">G</sup>
###xml 270 271 270 271 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r42">42</xref>
###xml 128 132 <span type="species:ncbi:10116">rats</span>
###xml 407 410 <span type="species:ncbi:10116">rat</span>
###xml 505 510 <span type="species:ncbi:10090">mouse</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 715 719 <span type="species:ncbi:10090">mice</span>
Our findings stress the impact of RAGE in generation of iNOS and nitrite and nitrate and cGMP, especially consequent to I/R. In rats rendered diabetic with STZ, the impact of diabetes and NOS in the heart was demonstrated by the beneficial effects of l-NAME (l-NG-nitro-l-arginine methyl ester) in improvement of ventricular performance (42). Our findings extend these concepts to link RAGE in the diabetic rat heart and RAGE signaling in either mononuclear phagocyte or endothelial cells in the diabetic mouse heart to iNOS expression and enhanced injury in I/R, as measured by LDH release. The finding that levels of ATP are restored in diabetic RAGE-KO mice or Tg mice expressing signaling-deficient mutant RAGE mice in I/R provides a direct link between oxidant stress, NOS, and energy metabolism.
###end p 74
###begin p 75
###xml 24 28 <span type="species:ncbi:10116">rats</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
###xml 902 906 <span type="species:ncbi:10090">mice</span>
Our studies in diabetic rats definitively showed that pharmacological blockade of RAGE protected the isolated perfused heart from damage and dysfunction, the latter measured by LVDP. In parallel, release of LDH was attenuated by RAGE blockade. In mice, pharmacological blockade of RAGE or genetic manipulation (RAGE-KO) attenuated the release of LDH and improved LVDP and ATP recovery. Although RAGE signaling significantly affected I/R injury and iNOS expression in diabetes, there was no effect on functional recovery in DN RAGE Tg mice. However, studies in mice globally deficient in RAGE displayed improvement in functional recovery consequent to I/R. These findings suggest a number of possibilities. First, it is plausible that distinct cell types expressing basal levels of RAGE, such as cardiomyocytes or T lymphocytes, may contribute to the findings on functional recovery observed in RAGE-KO mice. Second, the interplay between inflammatory cell and endothelial RAGE signaling may be a critical component of the biochemical and molecular events that, taken together, augur impairment in functional recovery in the I/R diabetic heart. Thus, future studies must address distinct signal transduction mutants of RAGE to broadly probe the potential effects of RAGE signaling in alternative cell types.
###end p 75
###begin p 76
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r43">43</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r44">44</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r45">45</xref>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r45">45</xref>
###xml 445 448 <span type="species:ncbi:10116">rat</span>
###xml 561 566 <span type="species:ncbi:10090">mouse</span>
These studies support that the ligands of RAGE, upregulated in the diabetic heart, play important roles in transducing the long-term impact of hyperglycemia. Certainly, basally increased levels of AGEs in the hyperglycemic heart may set the stage for amplification of injury, via RAGE, on superimposed I/R. Distinct RAGE ligands, such as S100/calgranulins may also play important roles in the I/R heart. In the isolated perfused heart, ischemic rat hearts release S100b (43). Studies have linked S100b to maladaptive remodeling after experimental infarction in mouse models (44). Our recent studies, performed in the absence of diabetes, demonstrated that a primary stimulus to release and recruitment of the RAGE axis ensues primarily from the ischemic insult (45). Ischemic insult induces increases in AGE-RAGE expression and leads to increased injury (45).
###end p 76
###begin p 77
###xml 214 218 <span type="species:ncbi:10090">mice</span>
In this study, we show that diabetes increases AGEs such as CML, pentosidine, and furosine under baseline and I/R conditions. Levels of CML, pentosidine, and furosine were significantly reduced in diabetic RAGE KO mice hearts. Targeted expression of DN RAGE in endothelial cells or mononuclear phagocytes attenuated CML accumulation in these diabetic hearts under all perfusion conditions, whereas pentosidine was attenuated in diabetic Tg DN MSR RAGE after I/R and furosine was attenuated in diabetic Tg DN PEET RAGE hearts after I/R. These data indicate that CML is a key AGE that is linked to RAGE-dependent injury after I/R in diabetic hearts. Taken together, our findings highlight potential roles for the RAGE axis at multiple stages of injury in the diabetic, ischemic heart.
###end p 77
###begin p 78
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r46">46</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r50">50</xref>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
We observed that in diabetic RAGE KO, Tg DN PPET RAGE, and Tg DN MSR RAGE mice hearts, protection from injury due to I/R was also associated with reductions in caspase-3 activation and cytochrome c release. These experiments are consistent with our and other earlier studies that have linked protection of ischemic hearts to reduced apoptosis in mice models of I/R including in the setting of diabetes (46-50)
###end p 78
###begin p 79
In conclusion, these studies definitively link RAGE to myocardial ischemic injury and dysfunction in the diabetic heart. We propose that blockade of RAGE may provide a novel means to exert cardioprotection in the vulnerable diabetic heart, particularly consequent to I/R injury.
###end p 79
###begin p 80
A.M.S. is a recipient of a Juvenile Diabetes Research Foundation Scholar Award. R.R. is an Established Investigator of the American Heart Association. This work was supported by grants from the U.S. Public Health Service (HL61783, HL68954, HL60901, and AG18436), the Juvenile Diabetes Research Foundation International, and the LeDucq Foundation.
###end p 80
###begin title 81
REFERENCES
###end title 81
###begin p 82
###xml 127 128 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 133 134 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 171 172 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 177 178 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 209 210 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 215 216 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 360 361 360 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 415 416 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J</italic>
###xml 473 474 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 498 499 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 583 584 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 587 588 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 36 39 <span type="species:ncbi:10116">rat</span>
###xml 78 82 <span type="species:ncbi:10116">rats</span>
###xml 504 508 <span type="species:ncbi:10116">rats</span>
###xml 593 597 <span type="species:ncbi:10116">rats</span>
RAGE, its ligands, and the diabetic rat heart. Hearts of type 1 diabetic BB/W rats were retrieved. Immunostaining of CML/AGEs (A and B), S100/calgranulin (C and D), RAGE (E and F), and nitrotyrosine epitopes (G and H) in nondiabetic and diabetic hearts is shown. RAGE was expressed in endothelial cells and mononuclear phagocytes, evident using anti-RAGE IgG (I and K), anti-CD31 IgG (to detect endothelial cells) (J), and anti-Mac-3 IgG (to detect mononuclear phagocyte) (L). Scale bar = 100 mum. n = 3 rats/group. Western blotting using anti-RAGE IgG was performed to detect RAGE (M). n = 6 rats/group.
###end p 82
###begin p 83
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 245 246 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 258 259 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 276 277 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 33 36 <span type="species:ncbi:10116">rat</span>
###xml 91 95 <span type="species:ncbi:10116">rats</span>
###xml 282 286 <span type="species:ncbi:10116">rats</span>
Diabetes upregulates iNOS in the rat heart: effect of RAGE. Hearts of type 1 BB/W diabetic rats treated with sRAGE or PBS were retrieved, and Western blotting was performed for detection of iNOS (A) antigen. Levels of total nitrite and nitrate (B) and cGMP (C) were measured. n = 6 rats/group. D, diabetic; ND, nondiabetic.
###end p 83
###begin p 84
###xml 179 180 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 202 203 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 244 245 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 56 59 <span type="species:ncbi:10116">rat</span>
###xml 104 108 <span type="species:ncbi:10116">rats</span>
###xml 250 254 <span type="species:ncbi:10116">rats</span>
Diabetes enhances cardiac dysfunction and injury in the rat heart: effect of RAGE. Type 1 BB/W diabetic rats received 500 mug/day sRAGE or PBS. Changes in cardiac function, LVDP (A) and release of LDH (B) in hearts subjected to I/R, are shown. n = 6 rats/group. D, diabetic; ND, nondiabetic.
###end p 84
###begin p 85
###xml 252 253 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 265 266 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 313 314 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 323 324 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 363 364 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 377 378 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 106 112 <span type="species:ncbi:10090">murine</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
Impact of RAGE in I/R in the diabetic mouse heart: sRAGE. BALB/c mice were rendered diabetic with STZ and murine sRAGE (100 mug/day) or vehicle administered. After 2 weeks, hearts were retrieved and subjected to Western blotting for detection of RAGE (A) and iNOS (B) antigens. Levels of total nitrite + nitrate (C), cGMP (D), and LDH release during reperfusion (E) are shown. n = 6 mice/group. D, diabetic; ND, nondiabetic.
###end p 85
###begin p 86
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 253 254 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 271 272 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
Impact of RAGE in I/R in the diabetic mouse heart: studies in homozygous RAGE-KO mice. After 12 weeks of diabetes, hearts of diabetic RAGE-KO or wild-type mice were retrieved and subjected to I/R. After I/R, LVDP recovery (A), LDH release (B), and ATP (C) were assessed. n = 5 mice/group. D, diabetic; WT, wild type.
###end p 86
###begin p 87
###xml 135 136 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 222 223 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 242 243 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 279 280 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 292 293 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 358 359 358 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
Impact of RAGE in I/R in the diabetic mouse heart: endothelial cell DN RAGE. Hearts of diabetic Tg PPET-DN-RAGE were subjected to I/R (A). Western blots for detection of iNOS antigen were performed at the end of ischemia (B) and reperfusion (C). Levels of total nitrite+nitrate (D) and cGMP (E), LDH release (F), and ATP (G) at the end of I/R were measured. n = 9 mice/group. D, diabetic; WT, wild type.
###end p 87
###begin p 88
###xml 297 298 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 316 317 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 353 354 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 383 384 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 396 397 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 434 435 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
Impact of RAGE in I/R in the diabetic mouse heart: mononuclear phagocyte DN RAGE. Tg mice expressing DN RAGE in mononuclear phagocytes were rendered diabetic with STZ. After 12 weeks, hearts were subjected to I/R. Western blots for detection of iNOS antigen were performed at the end of ischemia (A) or reperfusion (B). Levels of total nitrite+nitrate (C) and cGMP (D), LDH release (E), and ATP (F) were determined at the end of I/R. n = 9 mice/group. D, diabetic; WT, wild type.
###end p 88
###begin p 89
###xml 204 205 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 233 234 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 525 526 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
Impact of RAGE on apoptosis in diabetic hearts after I/R. Diabetic wild-type, RAGE KO, Tg DN PPET RAGE, and Tg DN MSR RAGE mice were subjected to I/R, and the hearts were assessed for caspase-3 activity (A) and cytochrome c release (B) at reperfusion. For cytochrome c (Cyt c) release, hearts were retrieved at reperfusion and subjected to Western blotting for detection of cytochrome c; blots were then stripped and re-probed with antibody for detection of GAPDH. Densitometry was performed and relative units reported from n = at least 5 mice per group. D, diabetic; WT, wild type.
###end p 89
###begin p 90
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Measurement of AGEs in diabetic BALB/c mice hearts under normoxic perfusion conditions
###end p 90
###begin p 91
Data are means +/- SD.
###end p 91
###begin p 92
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 vs. BALB/c-DM + sRAGE and BALB/c for CML comparison.
###end p 92
###begin p 93
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 vs. BALB/c furosine comparison.
###end p 93
###begin p 94
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 vs. BALB/c-DM + sRAGE and BALB/c for pentosidine comparison.
###end p 94
###begin p 95
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Measurement of AGEs in diabetic RAGE KO mice hearts under baseline normoxic and I/R conditions
###end p 95
###begin p 96
Data are means +/- SD.
###end p 96
###begin p 97
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 RAGE-KO-D vs. all other groups for CML comparison.
###end p 97
###begin p 98
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 wild-type-DM vs. all other groups for CML comparison.
###end p 98
###begin p 99
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 RAGE-KO-D vs. all other groups for pentosidine comparison.
###end p 99
###begin p 100
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 RAGE-KO-D, DNMSR vs. all other groups for pentosidine comparison.
###end p 100
###begin p 101
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 RAGE-KO-D vs. all other groups for furosine comparison.
###end p 101
###begin p 102
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 RAGE-KO-D, DNPPET vs. all other groups for furosine comparison. CML and furosine are expressed as mumol/mol lysine, whereas pentosidine is expressed as fmol/mg protein.
###end p 102
###begin p 103
Glucose levels
###end p 103
###begin p 104
###xml 62 66 <span type="species:ncbi:10116">rats</span>
###xml 108 123 <span type="species:ncbi:10090">transgenic mice</span>
Data are means +/- SD. Glucose levels were determined in BB/W rats, BALB/c, homozygous RAGE-KO, and DN RAGE transgenic mice at the time of death.
###end p 104
###begin p 105
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 vs. comparing diabetes with the absence of diabetes in respective controls.
###end p 105

